Rafferty Asset Management’s Nurix Therapeutics NRIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $862K | Sell |
75,723
-34,359
| -31% | -$391K | ﹤0.01% | 787 |
|
|
2025
Q1 | $1.31M | Sell |
110,082
-6,104
| -5% | -$72.5K | 0.01% | 681 |
|
|
2024
Q4 | $2.19M | Buy |
116,186
+22,593
| +24% | +$426K | 0.01% | 628 |
|
|
2024
Q3 | $2.1M | Sell |
93,593
-43,723
| -32% | -$982K | 0.01% | 623 |
|
|
2024
Q2 | $2.87M | Sell |
137,316
-74,109
| -35% | -$1.55M | 0.01% | 542 |
|
|
2024
Q1 | $3.11M | Buy |
+211,425
| New | +$3.11M | 0.01% | 575 |
|
|
2023
Q4 | – | Sell |
-98,839
| Closed | -$777K | – | 1090 |
|
|
2023
Q3 | $777K | Sell |
98,839
-15,649
| -14% | -$123K | ﹤0.01% | 853 |
|
|
2023
Q2 | $1.14M | Sell |
114,488
-25,659
| -18% | -$256K | 0.01% | 788 |
|
|
2023
Q1 | $1.24M | Sell |
140,147
-24,932
| -15% | -$221K | 0.01% | 743 |
|
|
2022
Q4 | $1.81M | Buy |
165,079
+34,170
| +26% | +$375K | 0.02% | 607 |
|
|
2022
Q3 | $1.71M | Buy |
130,909
+59,860
| +84% | +$780K | 0.02% | 546 |
|
|
2022
Q2 | $900K | Sell |
71,049
-75,231
| -51% | -$953K | 0.01% | 683 |
|
|
2022
Q1 | $2.05M | Buy |
146,280
+55,574
| +61% | +$778K | 0.01% | 594 |
|
|
2021
Q4 | $2.63M | Buy |
90,706
+31,840
| +54% | +$922K | 0.01% | 573 |
|
|
2021
Q3 | $1.76M | Sell |
58,866
-19,824
| -25% | -$594K | 0.01% | 676 |
|
|
2021
Q2 | $2.09M | Buy |
78,690
+10,863
| +16% | +$288K | 0.01% | 675 |
|
|
2021
Q1 | $2.11M | Buy |
+67,827
| New | +$2.11M | 0.01% | 606 |
|